pharma.markets

  • HOME
  • Imprint

COVID-19

Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents

09/04/2021 MaP 0

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today requested amendments to the U.S. Emergency Use Authorization (EUA) of the Pfizer-BioNTech vaccine (BNT162b2) to […]

Spain – The vaccination schedule: when will we be vaccinated?

07/04/2021 MaP 0

The vaccination strategy will pick up pace in the coming weeks, with a gradual and steady increase towards the end of the summer. The vaccination […]

Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months

01/04/2021 MaP 0

…Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective […]

BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

26/03/2021 MaP 0

BioNTech SE today announced that the European Medicines Agency (EMA) approved the manufacturing of the COVID-19 vaccine drug product at the facility in Marburg. As part […]

EMA Approves New Storage Option for Pfizer-BioNTech Vaccine, Easing Distribution and Storage of Doses Across European Union

26/03/2021 MaP 0

New stability data show vaccine can be stored at -25°C to -15°C for a total of two weeks and support decentralized distribution plans for vaccination […]

Comunidad Valencia – These are the groups to be vaccinated from 24.3.2021 onwards

24/03/2021 MaP 0

The reactivation of immunisation for the educational community will begin next Friday. The launch of the vaccination is to see, once again, the light at […]

Statement by HHS Secretary Xavier Becerra on the Anniversary of the Affordable Care Act

22/03/2021 MaP 0

“President Biden promised to bring down health care costs and that is exactly what we at the Department of Health and Human Services will do, […]

Spain – Vaccines stats on March 22nd 2021

22/03/2021 MaP 0

The autonomous communities have administered a total of 6,321,908 doses of Pfizer-BioNTech, Moderna and AstraZeneca’s covid-19 vaccines up to Monday, 328,545 of them during the […]

Clofamizine, a leprosy drug, is effective against SARS-CoV-2 infection

20/03/2021 MaP 0

Clofamizine, a drug used to treat leprosy, is effective against SARS-CoV-2 infection in human cells and hamsters, according to a study published Tuesday in the […]

IPS and BioKansas Partner to Host Community Forum – Cell & Gene Therapy

20/03/2021 MaP 0

This interactive forum discusses the latest in cell and gene therapy trends and their potential to impact the economy. Blue Bell, Pennsylvania, March 19, 2021 […]

Merck Accelerates European Expansion Plans for Single-use Products Critical to Manufacturing Vaccines and Lifesaving Therapies

17/03/2021 MaP 0

Merck will add a single-use assembly production unit at its Life Science Center in Molsheim, France. € 25 million investment in Molsheim, France, will create […]

Biden Administration to Invest $150 Million to Expand Access to COVID-19 Treatments in Underserved Communities

17/03/2021 MaP 0

As part of the Biden Administration’s ongoing efforts to promote health equity in response to the COVID-19 pandemic, the U.S. Department of Health and Human […]

Posts navigation

1 2 … 54 »

Translation

en English
ar Arabiczh-CN Chinese (Simplified)nl Dutchen Englishfr Frenchde Germanit Italianja Japaneseko Koreanpt Portugueseru Russianes Spanish

Search

Categories

  • Age.related Degeneration
  • Animal health
  • Asthma
  • Cancer
  • COVID-19
  • EIB
  • EU
  • FCPA Investigations
  • FDA
  • Finance
  • HHS
  • Humanitarian Aid
  • Imprint
  • Influenza
  • MS
  • News
  • Research
  • Rheumatology
  • Space Science
  • UN
  • Vaccines
  • Valencia Comunidad

Reports

  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents
  • Spain – The vaccination schedule: when will we be vaccinated?
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

Archive

  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
  • Pfizer and BioNTech Request Regulatory Agencies Expand Emergency Use of Their COVID-19 Vaccine to Adolescents

    09/04/2021 0
  • Spain – The vaccination schedule: when will we be vaccinated?

    07/04/2021 0
  • Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months

    01/04/2021 0
  • IPS Selected by Apiject as a Key Partner for Greenfield Blow−Fill−Seal Aseptic Manufacturing Campus

    30/03/2021 0
  • BioNTech provides Update on Vaccine Production Status at Marburg Manufacturing Site

    26/03/2021 0
Archives
  • April 2021 (3)
  • March 2021 (23)
  • February 2021 (22)
  • January 2021 (11)
  • December 2020 (29)
  • November 2020 (7)
  • October 2020 (6)
  • September 2020 (17)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (99)
  • May 2020 (201)
  • April 2020 (269)
  • March 2020 (29)
TAGS
affected africa aid biontech cancer commission companies coronavirus covid-19 covid19 crisis economy elpais.com eu europe european fda fight food global guarantee health hygiene italy links medical merck pandemic pfizer production products recommendations region response roche safety scheme sector spain state statistics stats support test vaccine

Copyright © 2021 | WordPress Theme by MH Themes